VANGUARD GROUP INC 13D and 13G filings for Vir Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:17 pm Purchase |
2023-12-29 | 13G | Vir Biotechnology, Inc. VIR |
VANGUARD GROUP INC | 12,297,139 9.140% |
2,202,638 (+21.82%) |
Filing |
| 2023-02-09 11:35 am Purchase |
2022-12-30 | 13G | Vir Biotechnology, Inc. VIR |
VANGUARD GROUP INC | 10,094,501 7.580% |
2,764,370 (+37.71%) |
Filing |
| 2022-02-10 08:42 am Purchase |
2021-12-31 | 13G | Vir Biotechnology, Inc. VIR |
VANGUARD GROUP INC | 7,330,131 5.600% |
7,330,131 (New Position) |
Filing |